May. 17 at 4:23 PM
$PCSA Processa Pharmaceuticals (NASDAQ: PCSA) shares are down over 70% since George Ng took over as CEO in August 2023.
Frankly, I give George credit for the company even being alive today. He had no idea what he was getting into when he took the job, he said virtually that to me on a call.
While a 70% decline since he was named CEO seems extreme, it probably should have been 100% with what he had to work with thanks to David Young. Had they not filed that premptive, frivelous, lawsuit at the suggestion of "someone" to stop Elion from taking back 6422, this would have been done some time ago.
George and Russell are both smart executives, but neither are Houdini. Sometimes the damage done in the past and at the hands of others, simply cannot be fixed.
